Form 4 for AVXL ANAVEX LIFE SCIENCES CORP.
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-24 · accession 0001731122-25-000452 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-24 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | F - Tax | $9.63 | -282.5K | 1.47M | -16% | -$2.72M |
| D | 2025-03-26 | 2025-03-24 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | M - OptEx | $0.92 | +500.0K | 1.75M | +40% | +$460.0K |
| D | 2025-03-26 | 2025-03-24 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | M - OptEx | $0.00 | -500.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | F | D | 282,497 | $9.63 | 1,467,713 | D | — | — | (F1) Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on April 2, 2025. The reporting person received 217,503 shares of common stock on net exercise of an option to purchase 500,000 shares of common stock. The Company withheld 282,497 shares of common stock underlying the option as consideration for the exercise price and tax withholdings, using the average of the high and low sales price on March 24, 2025 of $9.63, pursuant to the terms of the Company's 2007 Stock Option Plan. |
| 2 | Common | Common Stock | 2025-03-24 | M | A | 500,000 | $0.92 | 1,750,210 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-03-24 | M | D | 500,000 | $0.00 | 0 | D | $0.92 · 2015-04-02 to 2025-04-02 | 500,000 Common Stock |